ATLANTIC HEALTH SYSTEM
January 15, 2018
Kurt Jaeckle, MD, co-director of the Gerald J. Glasser Brain Tumor Center at Overlook Medical Center, and medical director of the Atlantic Center for Research, is leading a phase III study of novel drug VAL-083, which has already shown promise in Glioblastoma and other cancers.
The study is for patients whose glioblastoma multiforme or gliosarcoma has progressed during or after treatment ...
Read More »